In our previous studies, inspired by the binding principles of antibodies for soluble and insoluble Aβs, we designed a series of small fluorescent molecules to selectively detect soluble Aβs,8 the likely biomarker for the early stage of AD pathology. The gene discussed is DDX41; the disease is Alzheimer disease.